Skip to main content
. 2021 Oct 7;5(Suppl 2):e12589. doi: 10.1002/rth2.12589
Total population n = 1851

Anticoagulant use

(n = 287)

No anticoagulant use

(n = 1564)

P‐value Standardized mean difference

Anticoagulant use

(n = 253)

No anticoagulant use

(n = 253)

P‐value Standardized mean difference
Age*, years mean (SD) 76.75 (10.36) 64.54 (14.75) <0.001 0.957 76.47 (16.00) 75.89 (10.10) 0.523 0.012
Time in pandemic* in days, mean (SD) 45.69 (15.56) 46.88 (16.37) 0.253 0.075 45.55 (15.28) 46.96 (16.21) 0.419 0.071
Women*, n (%) 98 (34) 615 (39) 0.112 0.108 89 (35) 91 (36) 1.000 0.008
Diabetes*, n (%) 100 (35) 382 (25) <0.001 0.228 89 (35) 100 (39) 0.359 0.008
Asthma*, n (%) 21 (7) 171 (11) 0.077 0.128 20 (8) 23 (9) 0.750 0.045
Obesity*, n (%) 85 (32) 439 (30) 0.726 0.028 81 (32) 87 (34) 0.571 0.043
Hypertension, n (%) 168 (59) 684 (44) <0.001 0.296 152 (60) 156 (62) 0.785 0.032
Temperature at admission in °C, mean (SD) 37.68 (1.28) 37.82 (1.16) 0.062 0.116 37.70 (1.31) 37.81 (1.24) 0.308 0.091
Oxygen saturation in %, mean (SD) 93.2 (6.38) 93.1 (5.85) 0.737 0.021 93.3 (6.44) 92.9 (5.85) 0.453 0.067